Central Trust Company’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12
| Closed | -$4.15K | – | 1411 |
|
|
2024
Q1 | $4.15K | Hold |
12
| – | – | ﹤0.01% | 1189 |
|
|
2023
Q4 | $3.88K | Buy |
+12
| New | +$3.88K | ﹤0.01% | 1198 |
|
|
2023
Q3 | – | Sell |
-23
| Closed | -$8.72K | – | 1358 |
|
|
2023
Q2 | $8.72K | Sell |
23
-106
| -82% | -$40.2K | ﹤0.01% | 1042 |
|
|
2023
Q1 | $61.8K | Sell |
129
-6
| -4% | -$2.87K | ﹤0.01% | 749 |
|
|
2022
Q4 | $56.8K | Sell |
135
-395
| -75% | -$166K | ﹤0.01% | 748 |
|
|
2022
Q3 | $221K | Sell |
530
-19
| -3% | -$7.92K | 0.01% | 506 |
|
|
2022
Q2 | $272K | Buy |
549
+11
| +2% | +$5.45K | 0.01% | 474 |
|
|
2022
Q1 | $303K | Sell |
538
-7
| -1% | -$3.94K | 0.01% | 487 |
|
|
2021
Q4 | $412K | Sell |
545
-115
| -17% | -$86.9K | 0.01% | 468 |
|
|
2021
Q3 | $492K | Sell |
660
-35
| -5% | -$26.1K | 0.02% | 419 |
|
|
2021
Q2 | $448K | Sell |
695
-11
| -2% | -$7.09K | 0.02% | 423 |
|
|
2021
Q1 | $403K | Sell |
706
-90
| -11% | -$51.4K | 0.02% | 414 |
|
|
2020
Q4 | $464K | Sell |
796
-41
| -5% | -$23.9K | 0.02% | 376 |
|
|
2020
Q3 | $431K | Sell |
837
-39
| -4% | -$20.1K | 0.02% | 352 |
|
|
2020
Q2 | $396K | Sell |
876
-1,182
| -57% | -$534K | 0.02% | 355 |
|
|
2020
Q1 | $721K | Sell |
2,058
-4
| -0.2% | -$1.4K | 0.04% | 264 |
|
|
2019
Q4 | $763K | Hold |
2,062
| – | – | 0.04% | 292 |
|
|
2019
Q3 | $686K | Buy |
2,062
+2,042
| +10,210% | +$679K | 0.04% | 292 |
|
|
2019
Q2 | $6K | Buy |
20
+4
| +25% | +$1.2K | ﹤0.01% | 1019 |
|
|
2019
Q1 | $5K | Buy |
+16
| New | +$5K | ﹤0.01% | 992 |
|